Canopy Clinical Research

17/11/2025

Shingles Vaccine Study 👩‍⚕️

Canopy Clinical is looking for volunteers to participate in a shingles vaccine study. If you are aged 70 years or older and have never received a shingles vaccine, you may be eligible. Participants will be reimbursed for their time and involvement in the research study.

Enrolling at our Wollongong and Brookvale locations.

Get in touch to learn more! Click the link below and call our helpful team today on 0439 644 772.

https://canopycr.com.au/study/expressions-of-interest-shingles-vaccine-research-program/

13/05/2025

We are turning over a new leaf!

We are delighted to announce we have officially rebranded to Canopy Clinical Research!

This new chapter brings together our four research sites—Northern Beaches Clinical Research, Sutherland Shire Clinical Research, Wollongong Clinical Research, and Altona North Clinical Research—under one unified brand.

This change reflects who we are—a connected team with the shared vision of a world where the canopy of health embraces us all, ensuring every person has access to the care they deserve.

Get to know the Canopy community by heading to our brand-new website today: canopycr.com.au

18/11/2024

What is a medical trial, and why do people choose to participate?

Our Chief Executive Officer, Kris Barooshian, sat down with Starts at 60 to chat all things clinical trials.

If you are looking to learn more about clinical trials and how you can get involved, watch the video below.

To register for one of our studies, head to: https://northernbeachesclinicalresearch.com/studies/ #!/

Medical trials play a vital role in making medications safe. But what does it actually involve for those taking part? We chatted with Kris Barooshian, CEO of...

11/09/2024

New spots available on our RSV vaccine studies.

Northern Beaches Clinical Research is currently looking for local residents aged 60 and above to join our RSV research program.

This is your chance to give back to your community and help advance medicine.

Plus, you will be paid for your time and travel!

Call us today: 1300 637 175
https://northernbeachesclinicalresearch.com/studies/ #!/

29/07/2024

While RSV is more common in toddlers, older Australians are especially at risk of suffering from severe cases - experiencing similar symptoms and now similar rates of infection to the flu.

This year, there have been 124,000 recorded cases of RSV, signalling a 150% increase in cases from the same time in 2023.

TV and radio personality Ita Buttrose encourages Australians to be on the lookout for signs of infection in a recent 9 News segment, leading a national campaign to raise awareness about RSV.

Though an RSV vaccine for over 60s has recently been approved by the TGA, the need for further work in the area to improve accessibility and effectiveness remains a priority within the world of clinical research.

Read further about this story on the 9News website: https://www.9news.com.au/national/rsv-cases-rise-warning-older-people/9e148bf7-5804-446e-8e30-280f4a25983a

Interested in contributing to RSV research? Get in touch with us! You may be eligible to participate in a clinical trial. Visit our website at https://northernbeachesclinicalresearch.com/ and register your interest today.

22/07/2024

In anticipation of a future need to immunize against both SARS-CoV-2 and the influenza virus in advance of the winter transmission season, Northern Beaches Clinical Research is conducting multiple clinical studies on potential new vaccines to help protect you and your family.

Annual seasonal flu vaccinations and regular COVID-19 vaccinations are key strategies for preventing and reducing the severity of infections, particularly in high-risk individuals such as the elderly, young children, and the immunocompromised. As the viruses that cause these diseases continue to mutate year to year, the need for new and consistent research remains a necessity.

For more information on our current and future research studies investigating new COVID-19 and flu vaccines, please visit our website linked in our bio.

Interested in participating and giving back to the community? Give us a call on 1300 11 27 08 or register your interest on our website https://northernbeachesclinicalresearch.com/, , and our recruitment team can get in touch to assess your eligibility.

16/07/2024

Here at Northern Beaches Clinical Research, we are currently recruiting participants for a variety of research studies involving weight-loss and its effects on the risk of future health complications and comorbidities.

A weight-related comorbidity is a health problem that is either caused or made worse by being overweight or obese. Such conditions include heart disease, type 2 diabetes, high blood pressure and sleep apnoea.

Addressing and managing weight via early interventions can help reduce the risk and severity of these comorbidities, improving overall health outcomes.

Interested in participating? If you are currently experiencing or have a history of weight-related comorbidities, or would like to view further details about individual studies, visit our website at https://northernbeachesclinicalresearch.com/ or send us a direct message.

08/05/2024

This week is Heart Awareness Week, which is a fantastic opportunity for us all to start an important conversation about heart health and ways to minimise your risk of heart disease and severe cardiac events.

At Northern Beaches Clinical Research, we are currently recruiting patients for several clinical trials, which aim to investigate new potential treatments for weight-loss and cardiovascular disease.

Taking part in a clinical trial means you can play a vital role in improving cardiovascular care for potentially thousands of people in the future.

If you are interested in learning more about our studies, visit our website at Northern Beaches Clinical Research | Healthcare Through Cutting Edge Research or send us a direct message!


Diabetes Australia

05/04/2024

A huge congratulations to our Northern Beaches Clinical Research team, who this week successfully dosed their first patients in a new combined COVID-19 and Flu vaccine study 🎉